Alkermes plc researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL, and VUMERITY. The company is also developing LYBALVI, an oral atypical antipsychotic drug candidate.
Market Cap | 4.997 Billion | Shares Outstanding | 164.389 Million | Avg 30-day Volume | 1.003 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1 |
Price to Revenue | 4.152 | Debt to Equity | 0.291 | EBITDA | -88.826 Million |
Price to Book Value | 4.6279 | Operating Margin | -14.5581 | Enterprise Value | 4.254 Billion |
Current Ratio | 2.252 | EPS Growth | -1.632 | Quick Ratio | 1.764 |
1 Yr BETA | 0.4473 | 52-week High/Low | 32.23 / 21.75 | Profit Margin | -14.6505 |
Operating Cash Flow Growth | -113.0154 | Altman Z-Score | 2.4596 | Free Cash Flow to Firm | -108.027 Million |
Earnings Report | 2023-07-26 |
Please sign in first
none
71.2 Thousand total shares from 3 transactions
67.2 Thousand total shares from 5 transactions
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
7,479 | 2023-06-07 | 3 | |
NICHOLS CHRISTIAN TODD SVP, CHIEF COMMERCIAL OFFICER |
|
42,929 | 2023-06-05 | 5 |
|
27,071 | 2023-05-09 | 3 | |
POPS RICHARD F DIRECTOR AND CEO, ALKERMES PLC |
|
0 | 2023-02-23 | 2 |
LANDINE MICHAEL J SVP, CORP DEV., ALKERMES, INC. |
|
250,442 | 2023-02-22 | 2 |
BROWN IAIN MICHAEL SVP, CHIEF FINANCIAL OFFICER |
|
82,838 | 2023-02-22 | 2 |
GAFFIN DAVID JOSEPH EVP, CLO, ALKERMES, INC. |
|
126,853 | 2023-02-22 | 3 |
HOPKINSON CRAIG C. EVP R&D, CHIEF MEDICAL OFFICER |
|
56,559 | 2023-02-22 | 2 |
JACKSON BLAIR CURTIS EVP, CHIEF OPERATING OFFICER |
|
114,117 | 2023-02-22 | 2 |
|
25,169 | 2023-02-10 | 3 | |
|
95,169 | 2023-02-10 | 4 | |
|
17,511 | 2022-07-07 | 2 | |
|
17,511 | 2022-07-07 | 2 | |
|
17,511 | 2022-07-07 | 2 | |
|
17,511 | 2022-07-07 | 3 | |
|
17,511 | 2022-07-07 | 2 | |
|
17,511 | 2022-07-07 | 2 | |
|
84,905 | 2022-06-14 | 1 | |
|
53,124 | 2022-06-14 | 1 | |
|
10,330 | 2021-05-20 | 0 | |
|
18,174 | 2021-05-20 | 0 | |
FRATES JAMES M SVP, ALKS INC; CFO ALKS |
|
247,497 | 2020-05-14 | 0 |
|
0 | 2019-05-22 | 0 | |
ROBINSON JAMES A. JR. PRESIDENT & COO,ALKERMES, INC. |
|
4,412 | 2019-04-04 | 0 |
BIBERSTEIN KATHRYN L EVP/CAO/CCO/CRO ALKS INC; |
|
182,073 | 2018-03-01 | 0 |
STEJBACH MARK SVP/CHIEF COMM OFF, ALKS INC |
|
51,065 | 2018-03-01 | 0 |
EHRICH ELLIOT EVP, R&D & CMO, ALKERMES, INC. |
|
57,056 | 2017-05-28 | 0 |
PUGH GORDON G SVP, COO & CRO, ALKERMES, INC. |
|
No longer subject to file | 2016-12-31 | 0 |
PETERSON REBECCA SVP, CORPORATE COMMUNICATIONS |
|
2,644 | 2015-10-05 | 0 |
|
0 | 2014-05-28 | 0 | |
BOTKIN JAMES L SVP, ALKERMES GAINESVILLE LLC |
|
No longer subject to file | 2013-12-31 | 0 |
|
No longer subject to file | 2013-11-13 | 0 | |
|
No longer subject to file | 2012-03-13 | 0 | |
|
No longer subject to file | 2011-09-16 | 0 | |
|
No longer subject to file | 2011-09-16 | 0 | |
BROECKER DAVID A PRESIDENT & CEO |
|
106,616 | 2009-06-16 | 0 |
|
360,600 | 2007-06-15 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-06-07 17:12:25 -0400 | 2023-06-07 | M | 2,800 | $22.97 | a | 10,279 | direct | yes | ||||||||
2023-06-07 17:12:25 -0400 | 2023-06-07 | S | 2,800 | $31.50 | d | 7,479 | direct | yes | ||||||||
2023-06-07 17:12:25 -0400 | 2023-06-07 | M | 2,800 | d | 5,600 | direct | yes | |||||||||
NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER |
2023-06-06 17:31:06 -0400 | 2023-06-05 | F | 1,555 | $29.46 | d | 42,929 | direct | ||||||||
NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER |
2023-06-06 17:31:06 -0400 | 2023-06-05 | M | 3,500 | a | 44,484 | direct | |||||||||
NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER |
2023-06-06 17:31:06 -0400 | 2023-06-05 | M | 3,500 | d | 0 | direct | |||||||||
NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER |
2023-05-30 20:16:57 -0400 | 2023-05-30 | M | 19,634 | $20.43 | a | 68,118 | direct | yes | 1.2098 | 1.2098 | 2 | 0.0 | 1 | ||
NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER |
2023-05-30 20:16:57 -0400 | 2023-05-30 | M | 19,634 | d | 44,327 | direct | yes | ||||||||
NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER |
2023-05-30 20:16:57 -0400 | 2023-05-30 | S | 27,134 | $28.93 | d | 40,984 | direct | yes | 1.2098 | 1.2098 | 2 | 0.0 | 1 | ||
2023-05-10 16:34:10 -0400 | 2023-05-09 | M | 6,250 | $31.13 | a | 57,079 | direct | yes | -0.0641 | -3.2072 | 0.0 | 1 | -3.2072 | 6 | ||
2023-05-10 16:34:10 -0400 | 2023-05-09 | M | 6,250 | d | 0 | direct | yes | |||||||||
2023-05-10 16:34:10 -0400 | 2023-05-09 | M | 35,000 | $31.13 | a | 50,829 | direct | yes | -0.0641 | -3.2072 | 0.0 | 1 | -3.2072 | 6 | ||
2023-05-10 16:34:10 -0400 | 2023-05-09 | M | 35,000 | d | 0 | direct | yes | |||||||||
2023-05-10 16:34:10 -0400 | 2023-05-09 | S | 41,250 | $31.24 | d | 15,829 | direct | yes | -0.0641 | -3.2072 | 0.0 | 1 | -3.2072 | 6 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
ALKERMES PLC ALKS | 2023-06-07 22:15:04 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 21:45:05 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 21:15:04 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 20:45:04 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 20:15:06 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 19:45:04 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 19:15:04 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 18:45:04 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 18:15:03 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 17:45:05 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 17:15:04 UTC | 4.6619 | 0.4081 | 4600000 |
ALKERMES PLC ALKS | 2023-06-07 16:45:03 UTC | 4.6619 | 0.4081 | 4600000 |
ALKERMES PLC ALKS | 2023-06-07 16:15:04 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 15:45:04 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 15:15:04 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 14:45:04 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 14:15:03 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 13:45:03 UTC | 4.6619 | 0.4081 | 4500000 |
ALKERMES PLC ALKS | 2023-06-07 13:15:04 UTC | 4.6619 | 0.4081 | 4600000 |
ALKERMES PLC ALKS | 2023-06-07 12:45:04 UTC | 4.6619 | 0.4081 | 4600000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund | ALKS | -1284.0 shares, $-25615.8 | 2020-12-31 | N-PORT |
FundVantage Trust- Gotham Master Neutral Fund | ALKS | -278.0 shares, $-4606.46 | 2020-09-30 | N-PORT |
FundVantage Trust- Gotham Hedged Plus Fund | ALKS | -2332.0 shares, $-60935.16 | 2022-12-30 | N-PORT |